EA200000947A1 - Новые соединения бензотиофена, бензофурана и индола, способ их получения и содержащие их фармацевтические композиции - Google Patents

Новые соединения бензотиофена, бензофурана и индола, способ их получения и содержащие их фармацевтические композиции

Info

Publication number
EA200000947A1
EA200000947A1 EA200000947A EA200000947A EA200000947A1 EA 200000947 A1 EA200000947 A1 EA 200000947A1 EA 200000947 A EA200000947 A EA 200000947A EA 200000947 A EA200000947 A EA 200000947A EA 200000947 A1 EA200000947 A1 EA 200000947A1
Authority
EA
Eurasian Patent Office
Prior art keywords
group
atom
heterocycloalkyl
arylalkyl
cycloalkyl
Prior art date
Application number
EA200000947A
Other languages
English (en)
Other versions
EA004147B1 (ru
Inventor
Гийом Де Нантей
Кристин Лиля
Тони Верберен
Алан Рюпэн
Original Assignee
Адир Э Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Адир Э Компани filed Critical Адир Э Компани
Publication of EA200000947A1 publication Critical patent/EA200000947A1/ru
Publication of EA004147B1 publication Critical patent/EA004147B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)

Abstract

Соединения формулы (I)где X представляет атом кислорода, атом серы или группу NR, где Rтакой, как определен в описании,Y представляет атом кислорода, атом серы, группу NRили может в некоторых случаях представлять одинарную связь,T представляет атом азота, атом углерода или группу CH,A представляет одинарную связь, алкиленовую, ариленовую, циклоалкиленовую, гетероциклоалкиленовую или гетероариленовую группу или группу -SO-R-, где Rтакой, как определен в описании,W представляет гидрокси, алкокси, арилокси, арилалкокси, циклоалкилокси, гетероциклоалкилокси или гетероарилоксигруппу или гидроксиаминогруппу,Uпредставляет гетероатом или алкиленовую цепь, в которой один или несколько углеродных атомов могут необязательно быть заменены одним или несколькими гетероатомами,Vпредставляет ариленовую, гетероариленовую или гетероциклоалкиленовую группу,Uпредставляет одинарную связь, гетероатом или алкиленовую цепь, в которой один или несколько углеродных атомов могут необязательнобыть заменены одним или несколькими гетероатомами,Vпредставляет арильную, гетероарильную или гетероциклоалкильную группу,Ra, Rb и Rc, которые могут быть одинаковыми или разными, каждый независимо от других представляет группу, такую как определена в описании,Rпредставляет арильную группу, замещенную одним-пятью заместителями, 1,3-дигидро-2H-индол-2-оновую, 3,4-дигидро-2(1H)-хинолиноновую или 1-гидрокси-2(1H)-пиридиноновую группу или гетероарильную группу,Rпредставляет атом галогена или алкильную, арильную, арилалкильную, циклоалкильную, гетероциклоалкильную, гетероциклоалкилалкильную, гетероарильную или гетероарилалкильную группу,их изомеры и аддитивные соли с фармацевтически
EA200000947A 1999-10-15 2000-10-13 Производные бензотиофена и индола, способ их получения и содержащие их фармацевтические композиции EA004147B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9912899A FR2799756B1 (fr) 1999-10-15 1999-10-15 Nouveaux derives benzothiopheniques, benzofuraniques et indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
EA200000947A1 true EA200000947A1 (ru) 2001-04-23
EA004147B1 EA004147B1 (ru) 2004-02-26

Family

ID=9550989

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000947A EA004147B1 (ru) 1999-10-15 2000-10-13 Производные бензотиофена и индола, способ их получения и содержащие их фармацевтические композиции

Country Status (23)

Country Link
US (1) US6302837B1 (ru)
EP (1) EP1092716B1 (ru)
JP (1) JP3488683B2 (ru)
KR (1) KR100474753B1 (ru)
CN (1) CN1136213C (ru)
AT (1) ATE289305T1 (ru)
AU (1) AU774527B2 (ru)
BR (1) BR0005171A (ru)
CA (1) CA2323707C (ru)
DE (1) DE60018135T2 (ru)
DK (1) DK1092716T3 (ru)
EA (1) EA004147B1 (ru)
ES (1) ES2238261T3 (ru)
FR (1) FR2799756B1 (ru)
HK (1) HK1036447A1 (ru)
HU (1) HUP0004006A2 (ru)
MX (1) MXPA00010096A (ru)
NO (1) NO320693B1 (ru)
NZ (1) NZ507524A (ru)
PL (1) PL198579B1 (ru)
PT (1) PT1092716E (ru)
SI (1) SI1092716T1 (ru)
ZA (1) ZA200005668B (ru)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002529444A (ja) * 1998-11-12 2002-09-10 アリアド・ファーマシューティカルズ・インコーポレイテッド 二環式シグナル伝達阻害剤、それを含む組成物とその用途
JP2001261674A (ja) * 2000-03-22 2001-09-26 Mitsui Chemicals Inc ベンゾチオフェン誘導体およびそれを有効成分として含有する核内レセプター作動薬
JP2004501910A (ja) * 2000-06-28 2004-01-22 イーライ・リリー・アンド・カンパニー 新規なsPLA2インヒビター
US6969730B2 (en) * 2001-03-16 2005-11-29 Abbott Laboratories Amines as histamine-3 receptor ligands and their therapeutic applications
EP1844771A3 (en) 2001-06-20 2007-11-07 Wyeth Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
TWI224101B (en) * 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
ATE367812T1 (de) * 2001-06-20 2007-08-15 Wyeth Corp Substituierte indolsäurederivate als inhibitoren von plasminogen-aktivator-inhibitor-1 (pai-1)
US7348351B2 (en) 2002-12-10 2008-03-25 Wyeth Substituted 3-alkyl and 3-arylalkyl 1H-indol-1yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
UA80453C2 (en) * 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
CA2509238A1 (en) 2002-12-10 2004-06-24 Wyeth Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
WO2004052856A1 (en) * 2002-12-10 2004-06-24 Wyeth Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
CA2509191A1 (en) 2002-12-10 2004-06-24 Wyeth Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7351726B2 (en) * 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
US7411083B2 (en) 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7442805B2 (en) 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7141592B2 (en) * 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
US7754747B2 (en) 2004-08-23 2010-07-13 Wyeth Llc Oxazolo-naphthyl acids
CN101044136A (zh) 2004-08-23 2007-09-26 惠氏公司 作为pai-1抑制剂的吡咯基-萘基酸
AU2005277139A1 (en) * 2004-08-23 2006-03-02 Wyeth Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
WO2007022321A2 (en) * 2005-08-17 2007-02-22 Wyeth Substituted indoles and use thereof
EP2069354B1 (en) * 2006-08-21 2011-11-02 Genentech, Inc. Aza-benzofuranyl compounds and methods of use
MX2009001875A (es) * 2006-08-21 2009-03-02 Genentech Inc Compuestos de aza-benzotiofenilo y metodos de uso de los mismos.
US20080076750A1 (en) * 2006-09-15 2008-03-27 Aslanian Robert G Azetidinone Derivatives and Methods of Use Thereof
EP2066668A1 (en) * 2006-09-15 2009-06-10 Schering Corporation Spirocyclic azetidinone derivatives for the treatment of disorders of lipid metabolism, pain, diabetes and other disorders
MX2009002921A (es) * 2006-09-15 2009-04-01 Schering Corp Derivados de azetidinona para el tratamiento de trastornos del metabolismo lipidico.
JP2012513464A (ja) 2008-12-23 2012-06-14 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク ホスホジエステラーゼ阻害剤及びその使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
AU4321693A (en) * 1992-06-17 1994-01-04 Ciba-Geigy Ag Pyrimidinyl-and triazinyl compounds with herbicidal activity
US5334719A (en) * 1992-06-17 1994-08-02 Merck Frosst Canada, Inc. Bicyclic(azaaromatic)indoles as inhibitors of leukotriene bisynthesis
DE69327536T2 (de) * 1992-10-14 2000-07-06 Merck & Co., Inc. Fibrinogenrezeptor-antagonisten
US5288743A (en) * 1992-11-20 1994-02-22 Abbott Laboratories Indole carboxylate derivatives which inhibit leukotriene biosynthesis
GB9410387D0 (en) * 1994-05-24 1994-07-13 Xenova Ltd Pharmaceutical compounds
US6048877A (en) * 1997-02-21 2000-04-11 Bristol-Myers Squibb Company Tetralone derivatives as antiarrhythmic agents
FR2777886B1 (fr) * 1998-04-27 2002-05-31 Adir Nouveaux derives benzothiopheniques, benzofuraniques et indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HU0004006D0 (en) 2000-12-28
NZ507524A (en) 2002-03-01
PT1092716E (pt) 2005-05-31
EP1092716B1 (fr) 2005-02-16
US6302837B1 (en) 2001-10-16
CA2323707A1 (fr) 2001-04-15
PL343147A1 (en) 2001-04-23
MXPA00010096A (es) 2002-08-06
CN1293192A (zh) 2001-05-02
JP3488683B2 (ja) 2004-01-19
EP1092716A3 (fr) 2001-08-08
NO20005166D0 (no) 2000-10-13
EA004147B1 (ru) 2004-02-26
JP2001122876A (ja) 2001-05-08
ATE289305T1 (de) 2005-03-15
ES2238261T3 (es) 2005-09-01
SI1092716T1 (en) 2005-06-30
EP1092716A2 (fr) 2001-04-18
BR0005171A (pt) 2001-05-29
CA2323707C (fr) 2005-08-16
KR20010051018A (ko) 2001-06-25
HK1036447A1 (en) 2002-01-04
HUP0004006A2 (hu) 2002-04-29
PL198579B1 (pl) 2008-06-30
CN1136213C (zh) 2004-01-28
ZA200005668B (en) 2001-05-15
DE60018135D1 (de) 2005-03-24
AU774527B2 (en) 2004-07-01
NO320693B1 (no) 2006-01-16
NO20005166L (no) 2001-04-17
FR2799756B1 (fr) 2001-12-14
KR100474753B1 (ko) 2005-03-08
AU6650300A (en) 2001-04-26
FR2799756A1 (fr) 2001-04-20
DE60018135T2 (de) 2005-12-29
DK1092716T3 (da) 2005-05-17

Similar Documents

Publication Publication Date Title
EA200000947A1 (ru) Новые соединения бензотиофена, бензофурана и индола, способ их получения и содержащие их фармацевтические композиции
CY1108313T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
ES524236A0 (es) Un procedimiento para la preparacion de 1,4-dihidropiridina
RU2006137563A (ru) Способ получения аминофенольных соединений
FI843005A (fi) 1,6-naftyridinonderivat, deras framstaellningsfoerfarande och anvaendning vid foerhindrande av kaerl- sjukdomar.
ES545936A0 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina e isoquinolina
SA118390677B1 (ar) مشتقات ثنائي هيدرو بيريميدينون
KR880700798A (ko) 신규한 인데노티아졸유도체 및 그 제조법
GB1500255A (en) Process for the preparation of 2,4-dioxo-1,2,3,4-tetrahydro-s-triazine-(1,2-a)-benzimidazoles
DK160500C (da) Analogifremgangsmaade til fremstilling af 3-thiomethylpyridinderivater
DK412581A (da) Ethenylimidazolderivater og fremgangsmaade til fremstilling heraf
KR830002744A (ko) 구아니딘 화합물의 제조방법
KR840007420A (ko) 치환된 카복시-티아졸로[3,2-α] 피리미딘 유도체의 제조방법
TR200100673T2 (tr) Oksazol terkibinin üretim yöntemi